PROTAGONIST THERAPEUTICS INC (PTGX) Stock Earnings & Estimates
NASDAQ:PTGX - US74366E1029 - Common Stock
57.48 USD
+1.44 (+2.57%)
57.48 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 26.58M -2.85% | 60M 125.73% | 434.433M 624.06% | 58.431M -86.55% | 166.59M 185.11% | 210.96M 26.63% | 274.13M 29.94% | 471.96M 72.17% | 659.33M 39.70% | 839.49M 27.32% | 1.042B 24.12% | |
| EBITDA YoY % growth | -130.34M -4.24% | -90.34M 30.69% | 255.738M 383.08% | -146.15M -157.15% | 27.577M 118.87% | -34.614M -225.52% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -131.37M -4.39% | -93.652M 28.71% | 252.843M 369.98% | -136.729M -154.08% | -13.146M 90.39% | -93.746M -613.10% | 45.685M 148.73% | 238.9M 422.93% | 418.48M 75.17% | 621.85M 48.60% | 814.5M 30.98% | |
| Operating Margin | -494.24% | -156.09% | 58.20% | -234.00% | -7.89% | -44.44% | 16.67% | 50.62% | 63.47% | 74.07% | 78.17% | |
| EPS YoY % growth | -2.60 3.70% | -1.49 42.69% | 4.20 381.88% | -2.02 -148.06% | -0.97 51.85% | -1.13 -15.86% | 1.49 232.25% | 4.31 189.73% | 5.49 27.26% | 6.37 16.01% | 8.44 32.51% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.64 -18.04% | -0.60 -130.50% | -0.10 48.46% | -0.35 36.46% | -0.37 42.42% | 0.02 103.10% |
| Revenue Q2Q % growth | 3.74M -20.00% | 19.342M -88.66% | 50.911M 79.76% | 33.737M 508.31% | 34.298M 817.06% | 73.304M 278.99% |
| EBITDA Q2Q % growth | -48.96M -25.24% | -49.98M -138.54% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -46.357M -11.83% | -44.323M -134.96% | 39.822M 306.22% | -38.811M 7.68% | -39.576M 14.63% | 140.71M 417.47% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.55 -10.00% | -0.59 | 0.04 | 6.78% |
| Q1 2025 Q2Q % growth | -0.19 -105.83% | -0.24 | 0.05 | 19.40% |
| Q4 2024 Q2Q % growth | 1.98 350.00% | 0.33 | 1.65 | 504.52% |
| Q3 2024 Q2Q % growth | -0.54 6.90% | -0.62 | 0.08 | 12.85% |
| Q2 2024 Q2Q % growth | -0.50 26.47% | -0.61 | 0.11 | 18.53% |
| Q1 2024 Q2Q % growth | 3.26 586.57% | 1.22 | 2.04 | 167.72% |
| Q4 2023 Q2Q % growth | 0.44 163.77% | -0.03 | 0.47 | 1,399.31% |
| Q3 2023 Q2Q % growth | -0.58 9.38% | -0.71 | 0.13 | 18.05% |
| Q2 2023 Q2Q % growth | -0.68 19.05% | -0.66 | -0.02 | -2.99% |
| Q1 2023 Q2Q % growth | -0.67 -55.81% | -0.74 | 0.07 | 9.61% |
| Q4 2022 Q2Q % growth | -0.69 10.39% | -0.65 | -0.04 | -5.98% |
| Q3 2022 Q2Q % growth | -0.64 8.57% | -0.89 | 0.25 | 27.71% |
| Q2 2022 Q2Q % growth | -0.84 -21.74% | -0.95 | 0.11 | 11.13% |
| Q1 2022 Q2Q % growth | -0.43 20.37% | -0.64 | 0.21 | 32.91% |
| Q4 2021 Q2Q % growth | -0.77 -60.42% | -0.80 | 0.03 | 3.53% |
| Q3 2021 Q2Q % growth | -0.70 -233.33% | -0.68 | -0.02 | -2.43% |
| Q2 2021 Q2Q % growth | -0.69 -13.11% | -0.56 | -0.13 | -23.64% |
| Q1 2021 Q2Q % growth | -0.54 25.00% | -0.58 | 0.04 | 6.79% |
| Q4 2020 Q2Q % growth | -0.48 23.81% | -0.49 | 0.01 | 1.55% |
| Q3 2020 Q2Q % growth | -0.21 65.57% | -0.62 | 0.41 | 66.39% |
| Q2 2020 Q2Q % growth | -0.61 48.31% | -0.61 | 0.00 | -0.51% |
| Q1 2020 Q2Q % growth | -0.72 -24.14% | -0.71 | -0.01 | -2.01% |
| Q4 2019 Q2Q % growth | -0.63 | -0.66 | 0.03 | 4.68% |
| Q3 2019 Q2Q % growth | -0.61 | -0.73 | 0.12 | 16.24% |
| Q2 2019 Q2Q % growth | -1.18 | -0.29 | -0.89 | -313.17% |
| Q1 2019 Q2Q % growth | -0.58 | -0.60 | 0.02 | 2.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 5.546M 33.09% | 6.942M | -1.396M | -20.11% |
| Q1 2025 Q2Q % growth | 28.321M -88.89% | 31.053M | -2.732M | -8.80% |
| Q4 2024 Q2Q % growth | 170.638M 184.40% | 51.36M | 119.278M | 232.24% |
| Q3 2024 Q2Q % growth | 4.675M | 2.113M | 2.562M | 121.25% |
| Q2 2024 Q2Q % growth | 4.167M | 8.16M | -3.993M | -48.93% |
| Q1 2024 Q2Q % growth | 254.953M | 122.4M | 132.553M | 108.29% |
| Q4 2023 Q2Q % growth | 60M | 40.8M | 19.2M | 47.06% |
| Q3 2023 Q2Q % growth | 8.5M | -8.5M | -100.00% | |
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | 2.04M | -2.04M | -100.00% |
| Q4 2022 Q2Q % growth | -100.00% | 5.1M | -5.1M | -100.00% |
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | 860K -62.11% | 390.997K | 469.003K | 119.95% |
| Q1 2022 Q2Q % growth | 25.72M 315.51% | 17.391M | 8.329M | 47.89% |
| Q4 2021 Q2Q % growth | 8.62M 52.57% | 5.173M | 3.447M | 66.63% |
| Q3 2021 Q2Q % growth | 10.29M -21.51% | 1.778M | 8.512M | 478.74% |
| Q2 2021 Q2Q % growth | 2.27M -63.50% | 5.275M | -3.005M | -56.97% |
| Q1 2021 Q2Q % growth | 6.19M 69.59% | 1.53M | 4.66M | 304.58% |
| Q4 2020 Q2Q % growth | 5.65M 107.72% | 3.188M | 2.462M | 77.23% |
| Q3 2020 Q2Q % growth | 13.11M 216.67% | 2.193M | 10.917M | 497.81% |
| Q2 2020 Q2Q % growth | 6.22M 175.95% | 2.584M | 3.636M | 140.71% |
| Q1 2020 Q2Q % growth | 3.65M 133.97% | 1.51M | 2.14M | 141.72% |
| Q4 2019 Q2Q % growth | 2.72M | 3.29M | -570K | -17.33% |
| Q3 2019 Q2Q % growth | 4.14M | 4.923M | -783K | -15.90% |
| Q2 2019 Q2Q % growth | -8.19M | 11.424M | -19.614M | -171.69% |
| Q1 2019 Q2Q % growth | 1.56M | 5.003M | -3.443M | -68.82% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -6.42% | -13.36% | -1.83% | -4.23% |
| Revenue | -51.67% | -43.04% | -29.53% | -26.79% |